Diagnosing Rheumatoid Arthritis Early

Slides:



Advertisements
Similar presentations
Hatem H Eleishi, MD Professor of Rheumatology, Cairo University Consultant Rheumatologist, Dr. Soliman Fakeeh Hospital Rheumatoid Arthritis Wednesday,
Advertisements

Treatment Management of Rheumatoid Arthritis. Findings and In Depth Analysis.
Wrap-Up and Post Course Self Assessment Dr. Diane Lacaille.
Rheumatoid Arthritis Anila Malik GPVTS. Aims To cover the following: What is RA? Diagnostic criteria and clinical features Rheumatoid Factor Investigations.
EFFICACY OF SPA THERAPY IN RHEUMATOID ARTHRITIS-A RANDOMISED CONTROLLED CLINICAL STUDY Mine Karagülle Department of Medical Ecology and Hydroclimatology.
Rheumatoid Arthritis Dr Chandini Rao Consultant Rheumatologist.
Consultant Rheumatologist
Infectious arthritis Bacterial Viral Other Postinfectious (reactive) arthritis Rheumatic fever Reactive arthritis Enteric infection Other seronegative.
High Impact Rheumatology For Primary Care Physicians.
Rheumatology What we do & How to help Ronan Mullan.
Save The Date! Fatigue and Arthritis Wednesday 13 th April 2016 Holiday Inn-Southampton Free Health Care Professional Delegate Places Book Early Signed_________________.
Upfront Combination Therapy vs Step-Up Approach for PAH:
From: Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic AgentsA Cost-Effectiveness.
Rheumatoid Arthritis and Your Organs
ARTHRITIS & RHEUMATOLOGY
My Treatment Approach to Rheumatoid Arthritis
Glaucoma.
Psoriatic Arthritis.
A Fresh Look at Dry Eye.
Objective Assessment of RA: Expanding the Horizons
Clinical Developments in Inflammatory Arthritis 2017
Introduction/Background
The Patient Journey to Remission in MDD: A Collaborative Approach
Ask the Onychomycosis Expert, Part 1
The Latest Data on Oral Prostacyclin Therapy in PAH
Early Dementia Distinguishing AD From MCI
My Treatment Approach to Rheumatoid Arthritis
Updates in Management of Atopic Dermatitis From Real Patient Cases
Advances in Dry Eye.
Novel Small Molecule Therapies in Rheumatoid Arthritis
All About PAH:.
Managing RA: Telepartnership Between PCP and Rheumatologist
Wrap-Up and Post Course Self Assessment
Follow-Up of the Patient After PE
Decision-making in the eRA of Treating to Target
Precision Management of RA and Comorbidities
Clinical Updates in RA: New Developments and Insights From Washington
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Case Collection in RA: Highlights of an Interactive Workshop
Multidisciplinary Perspectives on Interstitial Lung Diseases
Contemporary Issues in Psoriasis Care: A Call to Action
Is RA Treatment Addressing the Real Needs of Patients?
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Debating the Issues in Rheumatoid Arthritis with the Experts: Early Treatment and Targets.
Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis.
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
When Is Biologic Therapy Appropriate for HS?
Improving Outcomes in Psoriatic Arthritis
Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.
Intro: Biomarkers in RA
Advancing Patient Care in RA
Challenges in Severe Asthma
Viewpoints of Practicing Rheumatologists: Case Discussions in RA
Shared Care Panel Discussion
EGPA.
Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.
Severe Asthma and Comorbidities
Updates in RA, PsA, and Biosimilars
Perspective on the Multidisciplinary Management of PAH
THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES
Diagnosing Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome
Merging the Art and Science of Managing nOH in Clinical Practice
Rheumatoid Arthritis.
The Building Blocks of Homocystinuria and Homocysteinemia Management
The Study Group aims to:
Foundations of Asthma.
Disease Activity Cutoffs for ACR-Recommended RA Disease Activity Measure
Meet the JAKs.
Management of NTM Lung Disease
Presentation transcript:

Diagnosing Rheumatoid Arthritis Early

Rheumatoid Arthritis

Inflammatory vs Noninflammatory Arthritis

ACR/EULAR Criteria for Diagnosing RA Before Joint Damage

Limitations to Classification of RA

Biomarkers in RA

Differential Diagnosis

Differential Diagnosis (cont)

Diagnostic Evaluation

Laboratory Tests and Radiographs

Importance of Early Treatment and Early Referral

Telemedicine Can Circumvent Delays In Evaluation and Treatment

Telerheumatology at Dartmouth-Hitchcock Medical Center

Telerheumatology Can Improve Access to Specialty Care for Patients With RA

Comorbidities Assessment and Management

DMARDs Cornerstone of Therapy for RA

DMARDs Cornerstone of Therapy for RA (cont)

DMARDs Cornerstone of Therapy for RA (cont)

DMARDs Cornerstone of Therapy for RA (cont)

When Response to DMARD Monotherapy Is Inadequate

Biologic Agents Used to Treat RA

Failure to Respond to Biologic Therapy

Monitoring Disease Activity Primarily the Responsibility of the Rheumatologist

Concluding Remarks